TP53, due to its ability to halt tumor progression by regulating apoptosis, angiogenesis, and DNA repair, may promote tumor cell metastasis through the accumulation of p53 molecules compared to wild-type TP53 leading to poor prognosis in HNSCC patients (82, 83). Here, TP53 is linked to head and neck squamous cell carcinoma.